Valuation: Seer, Inc.

Market Cap 112M 96.29M 90.09M 82.47M 155M 10.75B 157M 1.06B 415M 5.4B 422M 413M 17.87B P/E 2026 *
-1.85x
P/E 2027 * -1.99x
Enterprise Value 112M 96.29M 90.09M 82.47M 155M 10.75B 157M 1.06B 415M 5.4B 422M 413M 17.87B EV / Sales 2026 *
6.98x
EV / Sales 2027 * 5.79x
Free-Float
85.49%
Yield 2026 *
-
Yield 2027 * -
1 day+0.50%
1 week-2.40%
Current month-8.56%
1 month-1.93%
3 months+13.41%
6 months+2.53%
Current year+10.93%
1 week 2
Extreme 2
2.08
1 month 1.82
Extreme 1.82
2.25
Current year 1.55
Extreme 1.55
2.34
1 year 1.55
Extreme 1.55
2.41
3 years 1.46
Extreme 1.455
2.74
5 years 1.46
Extreme 1.455
45.85
10 years 1.46
Extreme 1.455
86.55
Manager TitleAgeSince
Chief Executive Officer 57 01/03/2018
Director of Finance/CFO 58 01/05/2020
Chief Operating Officer - -
Director TitleAgeSince
Chairman 57 01/09/2020
Director/Board Member 76 01/12/2017
Director/Board Member 70 01/12/2017
Date Insider Type Main position Quantity % Market Cap.
8/18/26 A Sell

Chief Financial Officer

-7,309 0.0132%
7/28/26 A Free

Director

41,500 0.0750%
7/28/26 A Free

Director

41,500 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
+0.50%-2.40%-3.79%-14.71% 112M
+0.14%-1.68%+5.58%+20.18% 27.96B
+0.22%-2.65%+11.20%-0.84% 7.47B
-1.57%+2.87%+2.25%+153.50% 3.5B
-2.99%-2.40%+9.70%-44.12% 2.94B
+0.80%-17.71%+52.62%+60.49% 2.23B
-1.00%-3.67%+104.86%+135.94% 1.86B
-0.36%+0.74%+7.67%+24.35% 1.76B
-2.99%-7.16%+6.79%+46.86% 1.3B
-0.15%+2.40%-37.13%-19.79% 871M
Average -0.74%-4.38%+15.98%+36.19% 5B
Weighted average by Cap. -0.27%-3.38%+11.56%+28.77%

Financials

2026 *2027 *
Net sales 16.1M 13.79M 12.9M 11.81M 22.17M 1.54B 22.46M 152M 59.45M 774M 60.45M 59.14M 2.56B 19.4M 16.62M 15.55M 14.23M 26.71M 1.86B 27.06M 184M 71.64M 932M 72.85M 71.26M 3.08B
Net income -61.2M -52.42M -49.05M -44.9M -84.27M -5.86B -85.38M -580M -226M -2.94B -230M -225M -9.73B -57.7M -49.43M -46.25M -42.33M -79.45M -5.52B -80.5M -546M -213M -2.77B -217M -212M -9.17B
Net Debt - -
Logo Seer, Inc.
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
Employees
124
Date Price Change Volume
21/08/26 $2.030 +0.50% 117,102
20/08/26 $2.020 -1.46% 176,515
19/08/26 $2.050 +1.49% 182,541
18/08/26 $2.020 -0.49% 258,293
17/08/26 $2.030 -2.40% 308,064
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.030USD
Average target price
4.000USD
Spread / Average Target
+97.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEER Stock